Beyond Air Inc
XAIR0.912USD
-0.015-1.67%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
7.30MMarket Cap
LossP/E TTM
More Details of Beyond Air Inc Company
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.
Beyond Air Inc Info
Ticker SymbolXAIR
Company nameBeyond Air Inc
IPO dateMay 07, 2019
CEOLisi (Steven A)
Number of employees61
Security typeOrdinary Share
Fiscal year-endMay 07
Address900 Stewart Ave
CityGARDEN CITY
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code11530
Phone15166658200
Websitehttps://www.beyondair.net/
Ticker SymbolXAIR
IPO dateMay 07, 2019
CEOLisi (Steven A)
Company Executives of Beyond Air Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. (Steve) Lisi
Mr. Steven A. (Steve) Lisi
Chief Executive Officer and Chairman of the Board
Chief Executive Officer and Chairman of the Board
172.07K
+3.61%
Mr. Robert Scott Goodman
Mr. Robert Scott Goodman
Interim Chief Commercial Officer, Director
Interim Chief Commercial Officer, Director
2.00K
--
Ms. Yoori Lee
Ms. Yoori Lee
Independent Director
Independent Director
633.00
--
Mr. Erick J. Lucera
Mr. Erick J. Lucera
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Gaul
Mr. Michael (Mike) Gaul
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Robert F. Carey
Mr. Robert F. Carey
Independent Director
Independent Director
--
--
Dr. William P. (Bill) Forbes
Dr. William P. (Bill) Forbes
Independent Director
Independent Director
--
-100.00%
Name
Name/Position
Position
Shareholding
Change
Mr. Steven A. (Steve) Lisi
Mr. Steven A. (Steve) Lisi
Chief Executive Officer and Chairman of the Board
Chief Executive Officer and Chairman of the Board
172.07K
+3.61%
Mr. Robert Scott Goodman
Mr. Robert Scott Goodman
Interim Chief Commercial Officer, Director
Interim Chief Commercial Officer, Director
2.00K
--
Ms. Yoori Lee
Ms. Yoori Lee
Independent Director
Independent Director
633.00
--
Mr. Erick J. Lucera
Mr. Erick J. Lucera
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Gaul
Mr. Michael (Mike) Gaul
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Robert F. Carey
Mr. Robert F. Carey
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Tue, Nov 18
Updated: Tue, Nov 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
9.48%
Balyasny Asset Management LP
5.80%
Carey (Robert F.)
3.47%
Lisi (Steven A)
2.15%
The Vanguard Group, Inc.
1.30%
Other
77.81%
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
9.48%
Balyasny Asset Management LP
5.80%
Carey (Robert F.)
3.47%
Lisi (Steven A)
2.15%
The Vanguard Group, Inc.
1.30%
Other
77.81%
Shareholder Types
Shareholders
Proportion
Hedge Fund
15.86%
Individual Investor
5.74%
Investment Advisor
3.40%
Investment Advisor/Hedge Fund
1.95%
Research Firm
0.31%
Other
72.75%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
151
628.12K
7.84%
-688.39K
2025Q2
165
1.63M
34.44%
-320.64K
2025Q1
178
31.62M
35.89%
-5.49M
2024Q4
179
32.21M
36.96%
-8.29M
2024Q3
180
25.32M
37.19%
+857.20K
2024Q2
181
20.67M
41.62%
-5.23M
2024Q1
170
25.39M
52.34%
+7.25M
2023Q4
164
17.21M
43.09%
+819.18K
2023Q3
159
14.91M
47.61%
-1.83M
2023Q2
159
14.94M
47.80%
+1.18M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Balyasny Asset Management LP
166.72K
3.11%
--
--
Jun 30, 2025
Carey (Robert F.)
277.68K
5.18%
--
--
Apr 23, 2025
Lisi (Steven A)
172.07K
3.21%
+6.00K
+3.61%
Jul 21, 2025
The Vanguard Group, Inc.
72.59K
1.35%
+9.37K
+14.82%
Jun 30, 2025
Bleichroeder LP
36.92K
0.69%
--
--
Jun 30, 2025
Avenue Capital Group
81.95K
1.53%
--
--
Jun 30, 2025
Kingdon Capital Management, L.L.C.
46.83K
0.87%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
41.92K
0.78%
+630.00
+1.53%
Jun 30, 2025
Wealth Effects LLC
13.90K
0.26%
+4.15K
+42.54%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
ProShares Hedge Replication ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
Global X Russell 2000 Covered Call ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 10, 2025
Merger
20→1
Date
Type
Ratio
Jul 10, 2025
Merger
20→1
FAQs
Who are the top five shareholders of Beyond Air Inc?
The top five shareholders of Beyond Air Inc are:
Balyasny Asset Management LP holds 166.72K shares, accounting for 3.11% of the total shares.
Carey (Robert F.) holds 277.68K shares, accounting for 5.18% of the total shares.
Lisi (Steven A) holds 172.07K shares, accounting for 3.21% of the total shares.
The Vanguard Group, Inc. holds 72.59K shares, accounting for 1.35% of the total shares.
Bleichroeder LP holds 36.92K shares, accounting for 0.69% of the total shares.
Balyasny Asset Management LP holds 166.72K shares, accounting for 3.11% of the total shares.
Carey (Robert F.) holds 277.68K shares, accounting for 5.18% of the total shares.
Lisi (Steven A) holds 172.07K shares, accounting for 3.21% of the total shares.
The Vanguard Group, Inc. holds 72.59K shares, accounting for 1.35% of the total shares.
Bleichroeder LP holds 36.92K shares, accounting for 0.69% of the total shares.
What are the top three shareholder types of Beyond Air Inc?
The top three shareholder types of Beyond Air Inc are:
Alyeska Investment Group, L.P.
Balyasny Asset Management LP
Carey (Robert F.)
Alyeska Investment Group, L.P.
Balyasny Asset Management LP
Carey (Robert F.)
How many institutions hold shares of Beyond Air Inc (XAIR)?
As of 2025Q3, 151 institutions hold shares of Beyond Air Inc, with a combined market value of approximately 628.12K, accounting for 7.84% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -26.60%.
What is the biggest source of revenue for Beyond Air Inc?
In --, the -- business generated the highest revenue for Beyond Air Inc, amounting to -- and accounting for --% of total revenue.
